丽珠集团:积极布局下一代产品线,多业务发展态势向好

财中社
Dec 26, 2025

丽珠集团(000513/01513)发布公告,丽珠集团于2025年12月25日举行了投资者关系活动,参与的投资机构共计13家。活动中,公司针对艾普拉唑片面临的仿制药竞争进行了讨论,指出虽然仿制药已在中国上市,但公司凭借在消化道领域的优势,仍实现了销售的稳定增长。公司还提到,针对未来可能的集采风险,已布局下一代消化道产品P-CAB——JP-1366,预计其片剂将于2028年开始销售。在精神分裂长效...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10